319 related articles for article (PubMed ID: 23442064)
21. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
[TBL] [Abstract][Full Text] [Related]
22. Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.
Pangalis GA; Kyrtsonis MC; Kontopidou FN; Siakantaris MP; Dimopoulou MN; Vassilakopoulos TP; Tzenou T; Kokoris S; Dimitriadou E; Kalpadakis C; Tsalimalma K; Tsaftaridis P; Panayiotidis P; Angelopoulou MK
Clin Lymphoma; 2005 Mar; 5(4):235-40. PubMed ID: 15794855
[TBL] [Abstract][Full Text] [Related]
23. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.
Jiménez C; Sebastián E; Chillón MC; Giraldo P; Mariano Hernández J; Escalante F; González-López TJ; Aguilera C; de Coca AG; Murillo I; Alcoceba M; Balanzategui A; Sarasquete ME; Corral R; Marín LA; Paiva B; Ocio EM; Gutiérrez NC; González M; San Miguel JF; García-Sanz R
Leukemia; 2013 Aug; 27(8):1722-8. PubMed ID: 23446312
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
[TBL] [Abstract][Full Text] [Related]
25. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
[TBL] [Abstract][Full Text] [Related]
26. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.
Stamatopoulos K; Belessi C; Moreno C; Boudjograh M; Guida G; Smilevska T; Belhoul L; Stella S; Stavroyianni N; Crespo M; Hadzidimitriou A; Sutton L; Bosch F; Laoutaris N; Anagnostopoulos A; Montserrat E; Fassas A; Dighiero G; Caligaris-Cappio F; Merle-Béral H; Ghia P; Davi F
Blood; 2007 Jan; 109(1):259-70. PubMed ID: 16985177
[TBL] [Abstract][Full Text] [Related]
27. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
[TBL] [Abstract][Full Text] [Related]
28. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
[TBL] [Abstract][Full Text] [Related]
29. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
Paiva B; Montes MC; García-Sanz R; Ocio EM; Alonso J; de Las Heras N; Escalante F; Cuello R; de Coca AG; Galende J; Hernández J; Sierra M; Martin A; Pardal E; Bárez A; Alonso J; Suarez L; González-López TJ; Perez JJ; Orfao A; Vidríales MB; San Miguel JF
Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227
[TBL] [Abstract][Full Text] [Related]
30. Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia.
Kristinsson SY; Björkholm M; Landgren O
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):187-90. PubMed ID: 23490991
[TBL] [Abstract][Full Text] [Related]
31. Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry.
Ocio EM; del Carpio D; Caballero Á; Alonso J; Paiva B; Pesoa R; Villaescusa T; López-Anglada L; Vidriales B; García-Sanz R
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):93-5. PubMed ID: 21454201
[TBL] [Abstract][Full Text] [Related]
32. The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS.
Klein CJ; Moon JS; Mauermann ML; Zeldenrust SR; Wu Y; Dispenzieri A; Dyck PJ
Can J Neurol Sci; 2011 Mar; 38(2):289-95. PubMed ID: 21320835
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.
Stamatopoulos K; Belessi C; Hadzidimitriou A; Smilevska T; Kalagiakou E; Hatzi K; Stavroyianni N; Athanasiadou A; Tsompanakou A; Papadaki T; Kokkini G; Paterakis G; Saloum R; Laoutaris N; Anagnostopoulos A; Fassas A
Blood; 2005 Nov; 106(10):3575-83. PubMed ID: 16076869
[TBL] [Abstract][Full Text] [Related]
34. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
[TBL] [Abstract][Full Text] [Related]
35. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.
Visco C; Maura F; Tuana G; Agnelli L; Lionetti M; Fabris S; Novella E; Giaretta I; Reda G; Barcellini W; Baldini L; Neri A; Rodeghiero F; Cortelezzi A
Clin Cancer Res; 2012 Apr; 18(7):1870-8. PubMed ID: 22322667
[TBL] [Abstract][Full Text] [Related]
36. Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL.
Aoki H; Takishita M; Kosaka M; Saito S
Blood; 1995 Apr; 85(7):1913-9. PubMed ID: 7703494
[TBL] [Abstract][Full Text] [Related]
37. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
[TBL] [Abstract][Full Text] [Related]
38. Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
McMaster ML; Kristinsson SY; Turesson I; Björkholm M; Landgren O
Clin Lymphoma Myeloma; 2009 Mar; 9(1):19-22. PubMed ID: 19362963
[TBL] [Abstract][Full Text] [Related]
39. Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
Trojani A; Greco A; Tedeschi A; Lodola M; Di Camillo B; Ricci F; Turrini M; Varettoni M; Rattotti S; Morra E
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):208-10. PubMed ID: 23477935
[TBL] [Abstract][Full Text] [Related]
40. IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.
Kryachok I; Abramenko I; Bilous N; Chumak A; Martina Z; Filonenko I
Med Oncol; 2012 Jun; 29(2):1093-101. PubMed ID: 21503826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
